RT Report
T1 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Children with a History of Multisystem Inflammatory Syndrome in Children: An International Survey.
A1 Hoste, Levi
A1 Soriano-Arandes, Antoni
A1 Buddingh, Emilie Pauline
A1 Whittaker, Elizabeth
A1 Belot, Alexandre
A1 Ulloa-Gutierrez, Rolando
A1 Olbrich, Peter
A1 Haerynck, Filomeen
K1 COVID-19
K1 MIS-C
K1 SARS-CoV-2
K1 adverse events
K1 vaccination
AB The optimal severe acute respiratory syndrome coronavirus 2 vaccine strategy for patients with a history of multisystem inflammatory syndrome in children (MIS-C) is unclear. We performed an international survey (32 countries) and found substantial variations in vaccine policies. Respondents did not report relapses of MIS-C or other severe inflammatory side effects after severe acute respiratory syndrome coronavirus 2 vaccination in 273 patients with a history of MIS-C.
PB Elsevier Inc.
YR 2022
FD 2022-09
LK http://hdl.handle.net/10668/22331
UL http://hdl.handle.net/10668/22331
LA en
NO Hoste L; MIS-C researchers; Soriano-Arandes A, Buddingh EP, Whittaker E, Belot A, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Children with a History of Multisystem Inflammatory Syndrome in Children: An International Survey. J Pediatr. 2022 Sep;248:114-118.
DS RISalud
RD Aug 23, 2025